Thailand has taken a major step in its healthcare journey as the Chulabhorn Royal Academy (CRA) launches Imcranib 100 for ...

Final analysis of the INTRIGUE trial shows ripretinib offers similar survival rates and better safety compared to sunitinib ...

Thailand has produced its first locally developed targeted therapy pill for cancer treatment. Imcranib 100 is the result of the scientific vision and leadership of Her Royal Highness Princess ...

Thailand has introduced its first domestically created targeted therapy pill for cancer treatment, named Imcranib 100.